Major progress has been made in the understanding not only of the mole
cular mechanisms involved in the pathogenesis of cancer, but also of t
he complex relations between cancer and the immune system. Among the m
ore promising approaches of gene therapy for cancer is the manipulatio
n of the immune system, with the development of an immune antitumoral
systemic response. Transfer of some cytokine gene in tumor cells has e
specially been shown to induce an immune response protecting the anima
l against subsequent injection of parental tumor cells, and can even,
in some cases, treat efficiently animals carrying a preexisting parent
al tumors. These new experimental data form the basis for the recent e
laboration of a rapidly increasing number of clinical protocols using
cytokine gene transfer for the treatment of human cancer.